Sort by:

• Highly Influential Citations
• Citations
• Acceleration
• Velocity
• Recency

Learn More

An Appeal to the Global Health Community for a Tripartite Innovation: An "Essential Diagnostics List," "Health in All Policies," and "See-Through 21(st) Century Science and Ethics".

• Edward S. Dove, I. Ömer Barlas, +35 authors Vural Özdemir
• Omics : a journal of integrative biology
• 2015

Diagnostics spanning a wide range of new biotechnologies, including proteomics, metabolomics, and nanotechnology, are emerging as companion tests to innovative medicines. In this Opinion, we present… (More)

Designing a post-genomics knowledge ecosystem to translate pharmacogenomics into public health action

• Edward S. Dove, Samer Faraj, Eugene Kolker, Vural Özdemir
• Genome Medicine
• 2012

Translation of pharmacogenomics to public health action is at the epicenter of the life sciences agenda. Post-genomics knowledge is simultaneously co-produced at multiple scales and locales by… (More)

Personalized medicine beyond genomics: alternative futures in big data—proteomics, environtome and the social proteome

• Vural Özdemir, Edward S. Dove, +7 authors Sanjeeva Srivastava
• Journal of Neural Transmission
• 2015

No field in science and medicine today remains untouched by Big Data, and psychiatry is no exception. Proteomics is a Big Data technology and a next generation biomarker, supporting novel system… (More)

A Systems Biology Approach to Reveal Putative Host-Derived Biomarkers of Periodontitis by Network Topology Characterization of MMP-REDOX/NO and Apoptosis Integrated Pathways

• Fares Zeidán-Chuliá, Mervi Gürsoy, Ben-Hur Neves de Oliveira, Vural Özdemir, Eija Könönen, Ulvi Kahraman Gürsoy
• Front. Cell. Infect. Microbiol.
• 2015

Periodontitis, a formidable global health burden, is a common chronic disease that destroys tooth-supporting tissues. Biomarkers of the early phase of this progressive disease are of utmost… (More)

Collective theranostics and postgenomics entrepreneurship: rethinking innovations as knowledge ecosystems built by complex collaboration.

• Samer Faraj, Eugene Kolker, Lisa Bevilacqua, Vural Özdemir
• Expert review of molecular diagnostics
• 2012

Some might think science is a romantic endeavor. The classic ‘Edisonian’ lens of science has advanced precisely that vision: ‘the lone genius’. While this (false) metaphor of solitary scientific… (More)

Theranostics, the 21st century bioeconomy and 'one health'. Interview by Tikki Pang.

• Vural Özdemir, Edward S. Dove
• Expert review of molecular diagnostics
• 2012

Tikki Pang was previously the Director of Research Policy & Cooperation and Senior Policy Adviser, Innovation, Information, Evidence & Research for the WHO in Geneva, Switzerland (1999–2012). He has… (More)

Theranostics: rethinking postgenomic diagnostics.

• Vural Özdemir, William Chi-shing Cho
• Expert review of molecular diagnostics
• 2012

Theranostics: towards postgenomic diagnostics Theranostics is a portmanteau word created by linguistically blending ‘therapeutics’ and ‘diagnostics’. Theranostics has indeed turned over a new leaf… (More)

Direct-to-consumer theranostics, 21st century collective innovation and entrepreneurship. Interview by Barbara Prainsack.

• Vural Özdemir, Edward S. Dove
• Expert review of molecular diagnostics
• 2012

What Role for Law, Human Rights, and Bioethics in an Age of Big Data, Consortia Science, and Consortia Ethics? The Importance of Trustworthiness

• Edward S. Dove, Vural Özdemir
• Laws
• 2015

The global bioeconomy is generating new paradigm-shifting practices of knowledge co-production, such as collective innovation; large-scale, data-driven global consortia science (Big Science); and… (More)

• ‹
• 1
• ›